Valneva Short Long Term Debt Total vs Common Stock Shares Outstanding Analysis
VALN Stock | USD 4.42 0.25 5.35% |
Valneva SE financial indicator trend analysis is much more than just breaking down Valneva SE ADR prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Valneva SE ADR is a good investment. Please check the relationship between Valneva SE Short Long Term Debt Total and its Common Stock Shares Outstanding accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Valneva SE ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
Short Long Term Debt Total vs Common Stock Shares Outstanding
Short Long Term Debt Total vs Common Stock Shares Outstanding Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Valneva SE ADR Short Long Term Debt Total account and Common Stock Shares Outstanding. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Valneva SE's Short Long Term Debt Total and Common Stock Shares Outstanding is 0.94. Overlapping area represents the amount of variation of Short Long Term Debt Total that can explain the historical movement of Common Stock Shares Outstanding in the same time period over historical financial statements of Valneva SE ADR, assuming nothing else is changed. The correlation between historical values of Valneva SE's Short Long Term Debt Total and Common Stock Shares Outstanding is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Short Long Term Debt Total of Valneva SE ADR are associated (or correlated) with its Common Stock Shares Outstanding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Common Stock Shares Outstanding has no effect on the direction of Short Long Term Debt Total i.e., Valneva SE's Short Long Term Debt Total and Common Stock Shares Outstanding go up and down completely randomly.
Correlation Coefficient | 0.94 |
Relationship Direction | Positive |
Relationship Strength | Very Strong |
Short Long Term Debt Total
Common Stock Shares Outstanding
The total number of shares of a company's common stock that are currently owned by all its shareholders.Most indicators from Valneva SE's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Valneva SE ADR current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Valneva SE ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. As of the 22nd of November 2024, Sales General And Administrative To Revenue is likely to grow to 0.35, while Selling General Administrative is likely to drop about 24.6 M.
2021 | 2022 | 2023 | 2024 (projected) | Total Operating Expenses | 221.6M | 150.3M | 134.9M | 141.7M | Cost Of Revenue | 187.9M | 324.4M | 100.9M | 58.6M |
Valneva SE fundamental ratios Correlations
Click cells to compare fundamentals
Valneva SE Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Valneva SE fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 264.7M | 449.2M | 817.4M | 621.3M | 460.1M | 252.3M | |
Short Long Term Debt Total | 85.2M | 105.5M | 114.7M | 152.4M | 208.8M | 219.3M | |
Other Current Liab | 27.0M | 51.7M | 342.6M | 200.2M | 93.7M | 98.4M | |
Total Current Liabilities | 41.3M | 175.9M | 369.0M | 277.4M | 158.9M | 166.8M | |
Total Stockholder Equity | 135.2M | 77.4M | 170.6M | 219.8M | 128.2M | 97.2M | |
Property Plant And Equipment Net | 69.3M | 78.2M | 173.8M | 154.0M | 156.6M | 164.4M | |
Net Debt | 20.8M | (98.9M) | (232.0M) | (137.0M) | 82.7M | 86.9M | |
Retained Earnings | (176.2M) | (233.5M) | (307.0M) | (450.3M) | (561.2M) | (533.1M) | |
Accounts Payable | 8.9M | 24.9M | 16.0M | 14.5M | 17.6M | 18.4M | |
Cash | 64.4M | 204.4M | 346.6M | 289.4M | 126.1M | 80.3M | |
Non Current Assets Total | 135.6M | 140.7M | 231.5M | 196.7M | 206.6M | 111.2M | |
Non Currrent Assets Other | 17.2M | 19.5M | 19.3M | 8.3M | 25.6M | 26.9M | |
Cash And Short Term Investments | 64.4M | 204.4M | 346.6M | 289.4M | 126.1M | 84.0M | |
Common Stock Shares Outstanding | 91.7M | 90.8M | 97.6M | 115.5M | 138.6M | 145.6M | |
Liabilities And Stockholders Equity | 264.7M | 449.2M | 817.4M | 621.3M | 460.1M | 252.3M | |
Non Current Liabilities Total | 88.3M | 195.9M | 277.8M | 124.2M | 182.3M | 191.4M | |
Other Current Assets | 14.9M | 57.8M | 71.0M | 76.2M | 50.6M | 53.2M | |
Other Stockholder Equity | 249.7M | 254.5M | 461.8M | 593.4M | 593.4M | 623.0M | |
Total Liab | 129.6M | 371.7M | 646.8M | 401.5M | 331.8M | 348.4M | |
Property Plant And Equipment Gross | 69.3M | 78.2M | 215.3M | 154.0M | 156.6M | 164.4M | |
Total Current Assets | 129.2M | 308.4M | 585.8M | 424.7M | 262.8M | 141.7M | |
Short Term Debt | 4.3M | 9.7M | 10.2M | 37.0M | 47.0M | 49.3M | |
Intangible Assets | 41.8M | 35.4M | 32.7M | 28.7M | 24.3M | 23.1M | |
Common Stock | 13.6M | 13.6M | 15.8M | 20.8M | 20.8M | 21.9M | |
Current Deferred Revenue | 1.1M | 89.6M | 124.0M | 9.4M | 5.7M | 5.4M | |
Net Receivables | 24.0M | 19.2M | 44.0M | 23.9M | 41.6M | 43.7M | |
Inventory | 25.8M | 26.9M | 124.1M | 35.1M | 44.5M | 28.5M | |
Accumulated Other Comprehensive Income | 48.0M | 52.3M | 52.5M | 55.3M | 75.3M | 79.0M | |
Other Assets | 21.7M | 24.1M | 26.8M | (2K) | (9.3M) | (8.9M) | |
Other Liab | 3.7M | 7.4M | 100.1M | 173.4M | 199.4M | 209.4M | |
Net Tangible Assets | 95.3M | 43.8M | 139.5M | 192.5M | 221.4M | 113.3M | |
Long Term Debt | 24.3M | 46.4M | 50.7M | 87.2M | 132.8M | 139.4M | |
Capital Lease Obligations | 58.9M | 52.1M | 56.8M | 53.6M | 32.0M | 48.3M | |
Deferred Long Term Liab | 2.0M | 1.7M | 1.6M | 1.4M | 1.3M | 1.5M | |
Net Invested Capital | 161.5M | 130.8M | 228.4M | 318.6M | 305.1M | 228.7M | |
Short Long Term Debt | 2.0M | 7.0M | 7.1M | 11.6M | 44.1M | 46.3M | |
Non Current Liabilities Other | 99K | 97.3M | 159.0M | 6.8M | 79K | 75.1K | |
Net Working Capital | 87.9M | 132.6M | 216.9M | 147.3M | 104.0M | 128.4M |
Pair Trading with Valneva SE
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Valneva SE position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Valneva SE will appreciate offsetting losses from the drop in the long position's value.Moving together with Valneva Stock
0.84 | VRAX | Virax Biolabs Group | PairCorr |
0.69 | VRPX | Virpax Pharmaceuticals | PairCorr |
0.77 | DYN | Dyne Therapeutics | PairCorr |
Moving against Valneva Stock
0.81 | PRAX | Praxis Precision Med | PairCorr |
0.77 | EWTX | Edgewise Therapeutics | PairCorr |
0.75 | VRDN | Viridian Therapeutics | PairCorr |
0.74 | AMLX | Amylyx Pharmaceuticals | PairCorr |
0.67 | AKRO | Akero Therapeutics | PairCorr |
The ability to find closely correlated positions to Valneva SE could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Valneva SE when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Valneva SE - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Valneva SE ADR to buy it.
The correlation of Valneva SE is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Valneva SE moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Valneva SE ADR moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Valneva SE can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Valneva SE ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Valneva SE. If investors know Valneva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Valneva SE listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.13) | Revenue Per Share 2.3 | Quarterly Revenue Growth 0.204 | Return On Assets (0.11) | Return On Equity (0.04) |
The market value of Valneva SE ADR is measured differently than its book value, which is the value of Valneva that is recorded on the company's balance sheet. Investors also form their own opinion of Valneva SE's value that differs from its market value or its book value, called intrinsic value, which is Valneva SE's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Valneva SE's market value can be influenced by many factors that don't directly affect Valneva SE's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Valneva SE's value and its price as these two are different measures arrived at by different means. Investors typically determine if Valneva SE is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Valneva SE's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.